Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

The world's most comprehensive cannabis strain directory, backed by scientific research.

Explore

Strain Directory Indica Strains Sativa Strains Hybrid Strains Breeders

Research

Research Database Medical Conditions Pain Relief Anxiety Insomnia

Tools

Strain Comparator Strain Explorer Blog API

© 2026 BudProfiles. For informational and educational purposes only.

Privacy Policy Terms of Service Disclaimer

11,121 strains · 12,304 studies · 268 breeders

Best Cannabis Strains for Dementia — 0 Strains, 0 Studies | BudProfiles

Home

Conditions

Dementia

Cannabis & Dementia

Explore 0 strains and 0 scientific studies related to Dementia.

0

Strains

0

Studies

19

Positive Studies

95%

Evidence Score

Research Evidence

19

Positive (95.0%)

1

Negative (5.0%)

0

Inconclusive (0.0%)

Scientific Studies

Δ9-Tetrahydrocannabinol (THC): A Critical Overview of Recent Clinical Trials and Suggested Guidelines for Future Research

2024·Clinical Trial

Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging

2024·Review/Other

Cannabidiol for behavior symptoms in Alzheimer’s disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial

2024·Double Blind Clinical Trial

Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer's Disease

2023·Review/Other

Examining the use of cannabidiol and delta-9-tetrahydrocannabinol-based medicine among individuals diagnosed with dementia living within residential aged care facilities: Results of a double-blind randomised crossover trial

2023·Double Blind Clinical Trial

Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report

2023·Review/Other

Synergetic effect of β-asarone and cannabidiol against Aβ aggregation in vitro and in vivo

2023·Animal Study -

Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer's disease: A systematic review and meta-analysis of animal studies

2023·Meta-analysis -

Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

2022·Meta-analysis -

Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP Swe /PS1ΔE9 Transgenic Female Mice

2022·Animal Study -

Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer’s Disease Rat Model: A Proof-of-Concept Study

2022·Animal Study -

Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents

2022·Review/Other

Gene Expression Analysis of the Endocannabinoid System in Presymptomatic APP/PS1 Mice

2022·Animal Study -

Impact of the cannabinoid system in Alzheimer's diseases

2022·Review/Other

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

2022·Meta-analysis -

LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility

2022·Review/Other

Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection

2022·Animal Study - Veterinary Clinical Trial

Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence

2022·Meta-analysis -

The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials

2022·Clinical Trial

Parkinson’s Disease and Dementia with Lewy Bodies, Patients Under Treatment with Standardized Extracts Enriched in Cannabidiol and Cannabigerol: Descriptive Observations in Preparation for a Phase 2a Clinical Trial

2022·Clinical Trial